Key result
Patients with congestive heart failure had significantly less epicardial fat mass assessed volumetrically by CMR compared with healthy controls (51 g vs. 65 g, p=0.01).
Why the study?
Does volumetric assessment of epicardial adipose tissue using CMR provide a more reproducible measure of epicardial fat compared to one-dimensional thickness measurements in patients with heart failure and healthy controls?
Observational (n=71)
Does volumetric assessment of epicardial adipose tissue using CMR provide a more reproducible measure of epicardial fat compared to one-dimensional thickness measurements in patients with heart failure and healthy controls?
Absolute Event Rate: 51% vs 65%
p-value: p=0.01
Volumetric assessment of epicardial fat mass using CMR is feasible and offers superior reproducibility compared to conventional one-dimensional thickness measurements.
Lower epicardial fat mass in heart failure was associated with disease status; hypothesis-generating for adipose remodeling and requires prospective validation before clinical use.
OBJECTIVE: Previous studies determined the amount of epicardial fat by measuring the right ventricular epicardial fat thickness. However, it is not proven whether this one-dimensional method correlates well with the absolute amount of epicardial fat. In this prospective study, a new cardiovascular magnetic resonance imaging (CMR) method using the three-dimensional summation of slices method was introduced to assess the total amount of epicardial fat. RESEARCH METHODS AND PROCEDURES: CMR was performed in 43 patients with congestive heart failure and in 28 healthy controls. The absolute amount of epicardial fat was assessed volumetrically in consecutive short-axis views by means of the modified Simpson's rule. Additionally, the right ventricular epicardial fat thickness was measured in two different imaging planes: long-axis view (EFT-4CV) and consecutive short-axis views (EFT-SAX). RESULTS: Using the volumetric approach, patients with congestive heart failure had less epicardial fat mass than controls (51 g vs. 65 g, p=0.01). This finding was supported by EFT-SAX (2.9 mm vs. 4.3 mm, p<0.0001) but not by EFT-4CV (3.5 mm vs. 3.8 mm, p=not significant). Epicardial fat mass correlated moderately with EFT-SAX in both groups (r=0.466, p=0.012 in controls and r=0.590, p<0.0001 in patients) and with EFT-4CV in controls (r=0.387, p=0.042). There were no significant differences between EFT-4CV and EFT-SAX in controls (4.3 mm vs. 3.8 mm, p=0.240). However, in the heart failure group, EFT-4CV was significantly higher compared with EFT-SAX (3.5 mm vs. 2.9 mm, p=0.003). Interobserver variability and reproducibility were superior for the volumetric approach compared with thickness measurements. DISCUSSION: Quantitative assessment of epicardial fat mass using the CMR-based volumetric approach is feasible and yields superior reproducibility compared with conventional methods.
No takes yet. Share an insight, caveat, or question.
Flüchter et al. (2007) conducted an observational in Congestive heart failure (n=71). Congestive heart failure vs. Healthy controls was evaluated on Epicardial fat mass (p=0.01). Patients with congestive heart failure had significantly less epicardial fat mass assessed volumetrically by CMR compared with healthy controls (51 g vs. 65 g, p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: